U.S. Physical Therapy (USPH) concentration risks

U.S. Physical Therapy's concentration exposure is rooted in payer mix rather than any single commercial customer. Medicare and Medicaid program coverage accounted for approximately 40.1% of visits and 35.8% of net patient revenue, a disclosed mid-range share that ties a meaningful portion of results to government reimbursement policy and rate-setting decisions rather than to a private counterparty relationship. That is a dependency-type exposure in the sense that changes to Medicare or Medicaid reimbursement rates could directly affect net patient revenue, even though the underlying payer is government rather than commercial. Beyond government programs, the business depends to a significant extent on its relationships with commercial health insurers, health maintenance organizations, preferred provider organizations, and workers' compensation insurers — another dependency-type exposure, though without a specific disclosed percentage. Together, these two exposures describe a physical therapy provider whose revenue is split across a public-payer channel with a known, sizable share and a private-payer channel whose relationships are qualitatively significant but not quantified. Neither is a structural feature unique to USPH's business model so much as a reflection of how physical therapy services are broadly reimbursed in the U.S. healthcare system, making regulatory and contracting developments across both channels the key variables to watch.

For the engine’s reasoning on USPH’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.